What we're reading, November 23, 2015: Oregon and California both pass laws that authorize pharmacists to prescribe birth control; the US and Europe are approving more drugs; and Turing discounts Daraprim just 50% and only for hospitals.
Oregon, California Authorize Pharmacists to Prescribe Birth Control
Pharmacists in Oregon and California will now be able to prescribe birth control to women without a doctor’s prescription. The states will authorize pharmacists to prescribe contraceptives after women fill out a questionnaire about their health and medical histories. The new legislation will provide easier access to birth control to millions of women. New Mexico and Nevada could follow, according to The New York Times.
More Drugs Being Approved in the US and Europe
The United States and Europe have been busy with drug approvals this year. In 2015, the FDA has already approved 38 novel drugs, which is more than the 34 at the same time a year ago. The total of 41 drugs approved in 2014 was an 18-year high that the FDA looks prepared to surpass. Meanwhile the European Medicines Agency has recommended a total of 84 drugs, which is up from the 75 drugs at the same time last year.
Turing Will Only Give 50% Discount on Daraprim to Hospitals
After public outrage over the news that Turing Pharmaceuticals AG had raised the price of a decades-old medication from $13.50 to $750, the company had promised to reduce the price. Now, Turing has announced it will discount the drug as much as 50% to hospitals, which will mean Daraprim still costs hospitals far more than before Turing raised the price more than 5000% overnight. In addition, the discount will not be given to patients who keep taking the drug after leaving the hospital, The Wall Street Journal reported.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis
April 23rd 2025Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen